close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
99 100 Next >
News headline image
Sensus SRTS Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers SRTS
Exposures Financial Product Safety
News headline image
ICU Medical (ICUI) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
Tickers ICUI
Exposures Product Safety Tariff
News headline image
Intellia Therapeutics Inc (NASDAQ:NTLA) Plummets 24.5% After FDA Places Clinical Hold on Phase 3 Trials ↗
Via Chartmill
Tickers NTLA
Exposures Product Safety
News headline image
MindMed (MNMD) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers MNMD
Exposures Financial Product Safety
News headline image
ATYR PHARMA INC (NASDAQ:ATYR) Shares Slide After Q3 Revenue and EPS Miss Estimates ↗
Via Chartmill
Tickers ATYR
Exposures Product Safety
News headline image
Sangamo (SGMO) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers PFE SGMO
Exposures Financial Product Safety
News headline image
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
Tickers AMZN BEAM CRSP EDIT MSFT NTLA
Exposures Artificial Intelligence Climate Intellectual Property
News headline image
Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know. ↗
Via The Motley Fool
Topics Earnings
Tickers LLY NVO
Exposures Financial Product Safety
News headline image
Higher-Dose Of Wegovy Demonstrates Weight Loss And Cardiovascular Benefits ↗
Via Benzinga
Tickers NVO
Exposures Product Safety
News headline image
Why QuidelOrtho (QDEL) Stock Is Down Today
Via StockStory
Tickers KO QDEL
Exposures Product Safety
News headline image
Gold Shines as Safe Haven Amidst Historic US Shutdown and Tariff Turbulence
Via MarketMinute
Topics Artificial Intelligence Economy Government
Tickers AAPL ABX AMZN CAT DE NVDA
Exposures Artificial Intelligence Economy Interest Rates
News headline image
UroGen (URGN) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers URGN
Exposures Financial Product Safety
News headline image
Minkang Zhang Advances Medical Device Software Through DevOps Optimization and Lifecycle Management
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Bio-Techne (TECH) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers TECH
Exposures Financial Product Safety
News headline image
Johnson & Johnson’s Newly Acquired Antipsychotic Drug Approved By FDA For Major Depressive Disorder ↗
Via Stocktwits
Tickers DUHP JGRO JNJ UBER
Exposures Product Safety
News headline image
Pulse Biosciences (PLSE) Earnings Transcript ↗
Via The Motley Fool
Tickers PLSE
Exposures Product Safety
News headline image
Sigyn Therapeutics Releases Shareholder Letter to Introduce CardioDialysis(TM)
Via NewMediaWire
Topics Intellectual Property
Tickers SIGY
Exposures Intellectual Property Product Safety
Sigyn Therapeutics Releases Shareholder Letter to Introduce CardioDialysis(TM)
Via TheNewswire.com
Topics Intellectual Property
Tickers SIGY
Exposures Intellectual Property Product Safety
News headline image
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
Via MarketMinute
Topics Intellectual Property
Tickers AGEN AMGN GILD HALO LGND LLY
Exposures Intellectual Property Product Safety
News headline image
Evolus (EOLS) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
Tickers EOLS
Exposures Financial Product Safety Tariff
News headline image
Disc Medicine Inc (NASDAQ:IRON) Reports Wider-Than-Expected Q3 2025 Loss Amid Pipeline Advancements ↗
Via Chartmill
Tickers IRON
Exposures Product Safety
News headline image
Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
News headline image
Levi & Korsinsky Reminds aTyr Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2025 - ATYR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers ATYR
Exposures Financial Legal Product Safety
News headline image
November 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
News headline image
November 7, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against SVRA
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
News headline image
Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
News headline image
Levi &amp; Korsinsky Reminds aTyr Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2025 - ATYR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers ATYR
Exposures Financial Legal Product Safety
News headline image
Achieve Life Sciences Inc (NASDAQ:ACHV) Stock Rises on FDA Priority Voucher News Despite Wider-Than-Expected Loss ↗
Via Chartmill
Tickers ACHV
Exposures Product Safety
News headline image
GH Research PLC (NASDAQ:GHRS) Reports Q3 2025 Earnings Beat and Clinical Progress ↗
Via Chartmill
Topics Earnings
Tickers GHRS
Exposures Financial Product Safety
News headline image
AstraZeneca Shares Jump; Drugmaker Keeps Outlook As Cancer Drug Sales Soar ↗
Via Investor's Business Daily
Tickers AZN
Exposures Product Safety
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today